NCT06632626

Brief Summary

Chemotherapy based on taxanes is commonly used to treat breast cancer. However, chemotherapy-induced peripheral neuropathy (CIPN), a side effect of taxanes, impairs a patient's grip strength, hand dexterity, and upper extremity function which affects quality of life (QOL).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 9, 2024

Completed
Last Updated

October 18, 2024

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

October 7, 2024

Last Update Submit

October 16, 2024

Conditions

Keywords

Breast cancerhand dexterityhand grip strengthtask-oriented trainingTaxanes-induced peripheral neuropathy

Outcome Measures

Primary Outcomes (3)

  • Hand grip strength

    Hand grip strength (HGS) was measured in the dominant hand for each patient using The CAMRY dynamometer

    At baseline and after four weeks of intervention.

  • Hand dexterity

    The nine-hole peg test was used to assess the hand dexterity

    At baseline and after four weeks of intervention.

  • Hand function

    Each patient was asked to answer the questions of the six scales in the Arabic version of Michigan hand questionnaire (1- Overall hand function, 2-Activities of Daily Living, 3- Work performance, 4- Pain, 5- Aesthetics, and 6- Satisfaction with hand function)

    At baseline and after four weeks of intervention.

Study Arms (2)

Task oriented training group

EXPERIMENTAL

This group included 30 patients suffering from taxanes induced peripheral neuropathy who received 30 minutes of task-oriented exercises, three sessions per week for four weeks along with 30 minutes of the traditional physical therapy.

Other: Task oriented training exercisesOther: Traditional physical therapy

Traditional physical therapy group

ACTIVE COMPARATOR

This group included 30 patients suffering from taxanes induced peripheral neuropathy who received 30 minutes of the traditional physical therapy only, three sessions per week for four weeks.

Other: Traditional physical therapy

Interventions

Task oriented training is a type of exercises in form of tasks using papers, pens, scissors, clips, coins, screws and clay

Task oriented training group

Traditional physical therapy inform of mobilization, strengthening exercises of hand and streching exercises.

Task oriented training groupTraditional physical therapy group

Eligibility Criteria

Age35 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiologically female patients only
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients were females only.
  • Their ages range from 35 to 65.
  • All patients suffered from CIPN after using taxanes (anti-cancer agent causing neurotoxic effect).
  • Diagnosis of CIPN was determined based on symptom history or the presence of stocking glove pattern "distal dysesthesias, pain and numbness" beginning after taxanes intake.
  • All patients enrolled to the study had their informed consent.
  • Patients suffer from affected brachial plexus.

You may not qualify if:

  • Patients had pain or numbness in the upper extremity due to other reasons like trauma (fracture), CNS diseases (cerebral infarction), other diseases with neurological symptoms like (diabetes, rheumatoid arthritis or cervical myelopathy).
  • Patients had bone, brain or spinal cord metastases.
  • Patients who had history of psychiatric disorders like: depression and schizophrenia or cognitive decline that may hinder them from active participation in the study.
  • Patients exhibited only acute neuropathy like in patients using oxaliplatin.
  • Patients had pain or numbness in the upper extremity due to other reasons like trauma (fracture), CNS diseases (cerebral infarction), other diseases with neurological symptoms like (diabetes, rheumatoid arthritis or cervical myelopathy).
  • Patients had bone, brain or spinal cord metastases.
  • Patients who had history of psychiatric disorders like: depression and schizophrenia or cognitive decline that may hinder them from active participation in the study.
  • Patients exhibited only acute neuropathy like in patients using oxaliplatin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of physical therapy, Cairo university

Giza, 11432, Egypt

Location

Related Publications (2)

  • Andersen Hammond E, Pitz M, Shay B. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment. Neurorehabil Neural Repair. 2019 Oct;33(10):792-799. doi: 10.1177/1545968319860486. Epub 2019 Jul 25.

    PMID: 31342880BACKGROUND
  • Andersen Hammond E, Pitz M, Steinfeld K, Lambert P, Shay B. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Neurorehabil Neural Repair. 2020 Mar;34(3):235-246. doi: 10.1177/1545968319899918. Epub 2020 Jan 24.

    PMID: 31976819BACKGROUND

MeSH Terms

Conditions

Peripheral Nervous System DiseasesBreast Neoplasms

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System DiseasesNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Shaimaa M A Elsayeh, PhD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single-blind, randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical Therapy Specialist

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 9, 2024

Study Start

September 1, 2023

Primary Completion

April 1, 2024

Study Completion

June 1, 2024

Last Updated

October 18, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations